Allstate (ALL) Stock Forecast & Price Target

Q: What analysts cover Allstate?

Allstate has been rated by research analysts at Barclays , Citigroup , Keefe, Bruyette & Woods , Mizuho , Piper Sandler , Raymond James Financial , The Goldman Sachs Group , Weiss Ratings , Wells Fargo & Company , and Zacks Research in the past 90 days.

$206.51 +0.42 (+0.20%)

Closing price 05/29/2026 03:59 PM Eastern

Extended Trading

$206.02 -0.49 (-0.24%)

As of 05/29/2026 07:57 PM Eastern

Compare

Allstate - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 21 Analyst Ratings

Sell
1

Hold
9

Buy
11

Based on 21 Wall Street analysts who have issued ratings for Allstate in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 21 analysts, 1 has given a sell rating, 9 have given a hold rating, 8 have given a buy rating, and 3 have given a strong buy rating for ALL.

Consensus Price Target

$241.67
17.02% Upside

According to the 21 analysts' twelve-month price targets for Allstate, the average price target is $241.67. The highest price target for ALL is $268.00, while the lowest price target for ALL is $208.00. The average price target represents a forecasted upside of 17.02% from the current price of $206.51.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for ALL and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Allstate and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ALL Analyst Ratings Over Time

Type	Current Forecast 6/1/25 to 6/1/26	1 Month Ago 5/2/25 to 5/2/26	3 Months Ago 3/3/25 to 3/3/26	1 Year Ago 6/1/24 to 6/1/25
Strong Buy	3 Strong Buy rating(s)	3 Strong Buy rating(s)	3 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	8 Buy rating(s)	8 Buy rating(s)	10 Buy rating(s)	13 Buy rating(s)
Hold	9 Hold rating(s)	9 Hold rating(s)	7 Hold rating(s)	1 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$241.67	$240.56	$239.29	$225.20
Forecasted Upside	17.02% Upside	10.80% Upside	12.03% Upside	7.42% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

ALL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ALL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Allstate Stock vs. The Competition

Type	Allstate	Finance Companies	Broader Market
Consensus Rating Score	2.62	2.30	2.52
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	17.02% Upside	26.62% Upside	14.83% Upside
News Sentiment Rating	Positive News See Recent ALL News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
5/28/2026	Piper Sandler 2 of 5 stars	Paul Newsome 2 of 5 stars	Reiterated Rating	Overweight
5/7/2026	Keefe, Bruyette & Woods 4 of 5 stars	Meyer Shields 3 of 5 stars	Boost Target	Outperform	$260.00 ➝ $266.00	+24.91%
5/6/2026	Wells Fargo & Company 3 of 5 stars	Elyse Greenspan 3 of 5 stars	Boost Target	Equal Weight	$229.00 ➝ $243.00	+11.19%
5/1/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Heimermann Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$221.00 ➝ $226.00	+4.01%
4/8/2026	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alex Scott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Underweight	$207.00 ➝ $208.00	-1.59%
4/7/2026	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Strong-Buy ➝ Hold
3/23/2026	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Buy (B+) ➝ Buy (A-)
3/20/2026	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yaron Kinar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$281.00 ➝ $265.00	+29.71%
3/5/2026	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy ➝ Neutral	$231.00	+7.73%
3/3/2026	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gregory Peters Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Strong-Buy	$260.00	+21.60%
Your book attached (Ad) Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing. Download the Safe Trade Options Formula book for free before access closes
2/5/2026	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jimmy Bhullar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$260.00 ➝ $263.00	+22.23%
2/5/2026	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Tunis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Neutral	$220.00	+2.11%
1/12/2026	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Buy ➝ Hold
1/7/2026	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Motemaden Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$225.00	+7.95%
12/18/2025	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Adam Klauber Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Outperform ➝ Market Perform
12/16/2025	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bob Huang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Overweight ➝ Equal Weight	$245.00 ➝ $215.00	+1.56%
11/26/2025	Roth Mkm Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Harry Fong Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$230.00 ➝ $240.00	+12.81%
11/10/2025	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Meredith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$250.00 ➝ $255.00	+24.72%
11/7/2025	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Zaremski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$235.00 ➝ $244.00	+23.29%
9/16/2025	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tracy Benguigui Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Strong-Buy
8/11/2025	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Andersen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$254.00 ➝ $255.00	+23.36%
3/3/2025	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Heal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Hold ➝ Buy
10/18/2024	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Buy	$216.00 ➝ $233.00	+19.62%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 03:50 AM ET.

Should I Buy Allstate Stock? ALL Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, May 31, 2026. Please send any questions or comments about these Allstate pros and cons to contact@marketbeat.com.

Allstate
Bull Case

Here are some ways that investors could benefit from investing in The Allstate Co.:

Recent earnings estimates for The Allstate Co. have been raised, indicating a stronger profitability outlook, with FY2026 EPS now projected at $28.20, up from previous estimates.
The current stock price is around $208.90, which is considered attractive given the company's strong fundamentals and recent performance.
Analysts have noted resilient margins and a positive outlook despite concerns about auto-margin deterioration, suggesting that the company is well-positioned in the market.
Institutional investors hold a significant portion of the company's stock, with 76.47% ownership, indicating confidence in The Allstate Co.'s long-term prospects.
Recent strong quarterly results showed an EPS of $10.65 and a 3% revenue increase, reflecting the company's solid operational performance.

Allstate
Bear Case

Investors should be bearish about investing in The Allstate Co. for these reasons:

The company is currently facing legal challenges related to a lawsuit involving an alleged psychology billing scheme, which could introduce uncertainty and affect its reputation.
Despite positive earnings revisions, some analysts maintain a "Hold" rating, suggesting caution and a lack of strong bullish sentiment in the market.
Recent price target adjustments by analysts have shown mixed sentiments, with some lowering their expectations, which may indicate a lack of consensus on the stock's future performance.
The stock has a relatively low P/E ratio, which could suggest that the market is pricing in potential risks or uncertainties regarding future growth.
Concerns about the overall economic environment and its impact on the insurance sector may lead to volatility in The Allstate Co.'s stock performance.

ALL Forecast - Frequently Asked Questions

According to the research reports of 21 Wall Street equities research analysts, the average twelve-month stock price forecast for Allstate is $241.67, with a high forecast of $268.00 and a low forecast of $208.00.

21 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Allstate in the last twelve months. There is currently 1 sell rating, 9 hold ratings, 8 buy ratings and 3 strong buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" ALL shares.

According to analysts, Allstate's stock has a predicted upside of 17.02% based on their 12-month stock forecasts.

Over the previous 90 days, Allstate's stock had 1 upgrade and 1 downgrade by analysts.

Allstate has been rated by research analysts at Barclays, Citigroup, Keefe, Bruyette & Woods, Mizuho, Piper Sandler, Raymond James Financial, The Goldman Sachs Group, Weiss Ratings, Wells Fargo & Company, and Zacks Research in the past 90 days.

Analysts like Allstate more than other "finance" companies. The consensus rating for Allstate is Moderate Buy while the average consensus rating for "finance" companies is Hold. Learn more on how ALL compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Allstate Recommendations

This page (NYSE:ALL) was last updated on 6/1/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Allstate (ALL) Stock Forecast & Price Target